These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31620452)

  • 21. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists.
    Singh A; Mehta Y
    J Anaesthesiol Clin Pharmacol; 2018; 34(2):161-165. PubMed ID: 30104821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart Failure with Preserved Ejection Fraction - Concept, Pathophysiology, Diagnosis and Challenges for Treatment.
    Miljkovik LV; Spiroska V
    Open Access Maced J Med Sci; 2015 Sep; 3(3):521-7. PubMed ID: 27275281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?
    Ahmed T
    Cureus; 2020 Mar; 12(3):e7323. PubMed ID: 32313764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Device-based treatment options for heart failure with preserved ejection fraction.
    Miyagi C; Miyamoto T; Karimov JH; Starling RC; Fukamachi K
    Heart Fail Rev; 2021 Jul; 26(4):749-762. PubMed ID: 33432418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interatrial shunt devices for heart failure with normal ejection fraction: a technology update.
    Cuthbert JJ; Pellicori P; Clark AL
    Med Devices (Auckl); 2017; 10():123-132. PubMed ID: 28652826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel approaches for left atrial pressure relief: Device-based monitoring and management in heart failure.
    Miyagi C; Kuroda T; Karimov JH; Fukamachi K
    Front Cardiovasc Med; 2022; 9():910957. PubMed ID: 36035901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Device Therapy for Heart Failure with Preserved Ejection Fraction.
    Salah HM; Levin AP; Fudim M
    Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular diastolic and systolic dyssynchrony and dysfunction in heart failure with preserved ejection fraction and a narrow QRS complex.
    Liu S; Guan Z; Jin X; Meng P; Wang Y; Zheng X; Jia D; Ma C; Yang J
    Int J Med Sci; 2018; 15(2):108-114. PubMed ID: 29333094
    [No Abstract]   [Full Text] [Related]  

  • 36. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the Efficacy of Interatrial Shunt Devices in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Abouzid MR; Ali K
    Cardiol Rev; 2024 Feb; ():. PubMed ID: 38323875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.